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Introduction: Eosinophilic panniculitis is an unusual type of panniculitis characterized by a prominent infiltration of
subcutaneous fat with eosinophils without an exact etiopathogenesis. To the best of our knowledge, up to now
eosinophilic panniculitis has been described in only one previous case with human immunodeficiency virus disease
in the literature.
Case presentation: Here we report the case of a 44-year-old Caucasian man, who is human immunodeficiency
virus positive, diagnosed with eosinophilic panniculitis. A dermatological examination revealed multiple, confluent
Kaposi’s sarcoma-like purple colored, deep plaques and nodules on his right gluteal area and right thigh. The
presence of the mixed inflammatory infiltrate of lymphocytes, macrophages, and numerous eosinophils involving
both septa and lobules of the subcutis were noted on the histopathological examination. On the basis of all these
clinical and histopathological findings the patient was diagnosed with eosinophilic panniculitis. He was given
intravenous 60mg/day methylprednisolone for 3 consecutive days a week for 6 months. The lesions resolved
almost completely after 6 months.
Conclusion: The predominance of T helper-2 subset of T helper cells and the consequential increase in
interleukin-5 cytokines accompanying peripheral eosinophilia and high serum immunoglobulin E levels may all be
blamed for the development of eosinophilic panniculitis in our case study. As a result, we aim to emphasize that
eosinophilic panniculitis should be kept in mind in the differential diagnosis of subcutaneous nodular lesions in
patients who are human immunodeficiency virus positive. We also focus on the requirement of histopathological
examination for the definitive diagnosis because the clinical features of eosinophilic panniculitis may easily be
confused with Kaposi’s sarcoma.
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Eosinophilic panniculitis (EP) is an unusual type of panni-
culitis characterized by a prominent infiltration of subcuta-
neous fat with eosinophils [1]. It is a reactive pattern that
may be associated with a variety of conditions such as
arthropod bites, parasitic infestations, drug reactions, vas-
culitis, neoplasm, or hematologic diseases. The exact patho-
genesis of the disease is still unclear. It is believed that in a
patient with immunodeficiency due to hematologic disease
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reproduction in any medium, provided the orproduction with an excess of interleukin (IL)-4 and IL-5
and an altered immune response with eosinophil predom-
inance [1]. In addition, in a patient with immunodeficiency
the infiltration may be the result of an antigenic trigger like
an insect bite, a drug, or a virus which causes cytokine pro-
duction with an excess of IL-4 and IL-5 and an altered im-
mune response with prominent infiltration of the septa
and/or lobules of the subcutaneous fat with eosinophils
leading to EP [1]. Here we report the case of a 44-year-old
man, who has the human immunodeficiency virus (HIV),
diagnosed with Kaposi’s sarcoma-like EP who responded
well to corticosteroids.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 The irregular shaped plaques with a pebbled surface
on patient’s right thigh.
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A 44-year-old White Caucasian man who is HIV positive
presented with multiple, pruritic, purplish colored pla-
ques on the gluteal areas and thigh for 3 months. He
was HIV positive for about 15 years. He was already at
the stage of late symptomatic acquired immunodefi-
ciency syndrome (AIDS) with a CD4 count of 350 cells/
mm3 for 6 months. The HIV ribonucleic acid (RNA)
titer was 7000 copies/mm3. His antiretroviral therapy
included 600mg twice a day indinavir, 100mg twice a
day ritonavir and 400mg lopinavir, 1200mg twice a day
nelfinavir, 600mg per day zidovudine, and 150mg per
day lamivudine. He had been treated with anti-HIV
drugs for the past 6 months. He was also taking prophy-
lactic azithromycin, dapsone, valacyclovir, gancyclovir
and antifungals. His past medical and family history
were unremarkable other than his HIV positivity. He de-
nied the presence of a previous trauma, atopy or an
arthropod bite. He also informed us that he had been
treated with intravenous (IV) methylprednisolone in 0.3
to 0.5mg/kg doses a few weeks before without an exact
histopathological diagnosis. A dermatological examin-
ation revealed multiple, confluent Kaposi’s sarcoma-like
purple colored, deep plaques and nodules on his right
gluteal area (Figure 1). There were also similar irregular
shaped plaques with a pebbled surface on his right thigh
(Figure 2). All the lesions were deeply extended through
the subcutaneous tissue. On histopathological examin-
ation it was observed that most of the inflammation was
in the subcutis, in and near the septa and lobulesFigure 1 Multiple, confluent, Kaposi’s sarcoma-like purple
colored, deep plaques and nodules on patient’s right gluteal
area.(hematoxylin and eosin stain ×40) (Figure 3). A mixed
inflammatory infiltrate of lymphocytes, macrophages,
and numerous eosinophils involving both septa and
lobules of the subcutis were noted. There was a marked
abundance of eosinophils in the infiltrate (Figure 4). The
full blood examinations and urine analysis were all nor-
mal other than a mild lymphopenia (0.8 × 109/L). TheFigure 3 On the histopathological examination most of the
inflammation was observed in the subcutis, in and near the
septa and lobules (hematoxylin and eosin ×40).
Figure 4 A mixed inflammatory infiltrate of lymphocytes,
macrophages, and numerous eosinophils involving both septa
and lobules of the subcutis (hematoxylin and eosin ×400).
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peripheral eosinophilia, nor an increase in total im-
munoglobulin E (IgE) level was observed. The serological
tests including polymerase chain reaction were negative
for Toxoplasma gondii, cytomegalovirus and human
herpes virus-8. Hepatitis markers and Venereal Disease
Research Laboratory tests were also negative. Direct radio-
graphies and microbiological cultures excluded the pres-
ence of an infection, parasitic infestations, neoplasm and
sarcoidosis. A punch biopsy sample was also sent for
Gram stain, acid-fast bacillus staining, and fungal cultures,
all of which were negative. With all these clinical and
histopathological findings the patient was diagnosed with
EP. He was given intravenous (IV) 60mg per day methyl-
prednisolone for 3 consecutive days a week for 6 months.
The lesions resolved almost completely after 6 months.
No recurrence was noted during 6 months of follow-up.
Discussion
EP is a histopathologic pattern rather than a distinct entity
[1]. Previous clinical studies have already revealed diverse
patterns of local and systemic diseases, including arthropod
bites, Wells’ syndrome presenting with eosinophilic cellu-
litis, immune complex vasculitis, atopy, erythema nodo-
sum, hematologic disorders like refractory anemia with
excess blasts, injection granuloma, streptococcal and other
bacterial infections, toxocariasis, malignancies like B- and
T-cell lymphoma, polyarteritis nodosa, eosinophilic fasci-
itis, eosinophilic folliculitis, hypereosinophilic syndrome,
eosinophilic neuritis, chronic recurrent parotitis, nephrotic
syndrome, glomerulonephritis, sarcoidosis, tuberculouspleurisy, larva migrans (gnathostomiasis), and psychiatric
illnesses like drug dependency [2-4]. The skin lesions
mostly vary from urticarial papules, plaques to purpura,
pustules, and ulcerative lesions but always include a nodu-
lar subcutaneous component [1]. Treatment is difficult and
recurrences are common. It is a self-limited disorder in
most cases, and has been shown to respond to prednisone,
but lesions often recur when the dose is reduced. Chemo-
therapy regimens may also improve the lesions in some
patients [1].
To the best of our knowledge, this is the second
reported HIV positive case with EP described in the litera-
ture. The first case was a 32-year-old African American
man with advanced AIDS who presented with generalized
painful, pruritic papular rash, peripheral blood eosino-
philia and perineural eosinophilic infiltrates with EP [5].
We propose that EP may represent additional findings in
the spectrum of cutaneous diseases seen in patients with
advanced AIDS. In later stages of HIV infection some im-
munologic abnormalities occur, such as a switch from pre-
dominately T helper-1 to T helper-2 subset of T helper
cells that produce IL-5: a cytokine involved in eosinophil
development and differentiation. The increase in IL-5 and
IL-4 may be responsible for the possible eosinophilia and
elevation of serum immunoglobulin E levels, respectively,
in HIV-related eosinophilic diseases like eosinophilic fol-
liculitis and EP [6]. However, we believe that the absence
of peripheral eosinophilia in our case might also have been
as a result of the previous corticosteroid treatments. In a
recently reported comparative study, HIV-related pruritic
papular eruption (HIV-PPE) and eosinophilic folliculitis
were quantitatively distinguished mainly by the histo-
pathological and immunohistochemical findings [7]. The
intense perivascular and diffuse inflammatory infiltration,
the tissue mast cell count by toluidine staining and ex-
pression levels of CD15 (for eosinophils), CD4 (T helper),
and CD7 (pan-T lymphocytes) seen in HIV-EP were
reported to be significantly higher than in HIV-PPE. The
blood eosinophils were found to be low in both groups as
in our case study. The difference of the percentage of the
eosinophilic infiltrates was also reported to be nonsignifi-
cant [7]. The clinical similarity of the lesions to Kaposi’s
sarcoma was also noteworthy in this case. Kaposi’s sar-
coma was also firstly considered in the differential diagno-
sis because the patient was HIV positive and the lesions
were vivid and purple colored. However, it was clearly
excluded by the histopathological examinations.
Conclusion
Although the etiology of EP is highly diverse and nonspe-
cific, it seems to be a unique histopathological reaction
pattern characterized by massive eosinophilic infiltration
into subcutaneous tissues. Once a diagnosis of EP has
been established, appropriate detailed evaluations for all
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formed. EP should also be kept in mind in the differential
diagnosis of the subcutaneous nodular lesions in patients
who are HIV positive, and histopathological examination
is mandatory for the definitive diagnosis. As a result, the
predominance of T helper-2 subset of T helper cells and
the consequential increase in IL-5 cytokines accompany-
ing peripheral eosinophilia and high serum IgE levels may
be blamed for the development of EP in patients who are
HIV positive.
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